Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]
ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer […]
DNA: New Method Analyses Changes with ‘Unprecedented Accuracy’
Scientists have developed a new sequencing method to study changes in the DNA of any […]
Transforming the UK into a Life Sciences Superpower
Patients are set to benefit from better research, treatment, care and improved clinical decision-making, as […]
Hancock: Modern Medicine May Cease to Exist Without Global AMR Action
Health and Social Care Secretary, Matt Hancock, will today call for urgent global action in […]
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the […]
GEN inCode Announces Major UK Collaboration
GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention […]
Peijia Medical TaurusOne® Approved for Commercialization
A new interventional solution from China for structural heart disease is about to be launched onto the […]
FDA Grants Accelerated Approval for GSK’s JEMPERLI (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has […]
Government Launches Covid-19 Antivirals Taskforce to Roll out Innovative Home Treatments This Autumn
A new Antivirals Taskforce has been launched by the government to identify treatments for UK […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more